Home Biotechnology Gene Vector Market Size, Share & Growth Report by 2034

Gene Vector Market Size & Outlook, 2026-2034

Gene Vector Market Size, Share & Trends Analysis Report By Type (Viral Vectors, Non-Viral Vectors), By Application (Gene Therapy, Vaccinology, Others), By Diseases (Oncology, Genetic Disorders, Infectious Diseases, Others), By End Use (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, CROs, CDMOs) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRBI57743DR
Last Updated : Nov, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Gene Vector Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Adenoviral vectors
            1. Adenoviral vectors By Value
          3. Adeno associated viral vectors
            1. Adeno associated viral vectors By Value
          4. Retroviral vectors
            1. Retroviral vectors By Value
          5. Lentiviral vectors
            1. Lentiviral vectors By Value
          6. Herpes Simplex Virus (HSV) Vectors
            1. Herpes Simplex Virus (HSV) Vectors By Value
          7. Others
            1. Others By Value
        3. Non-Viral Vectors
          1. By Value
          2. Plasmid DNA
            1. Plasmid DNA By Value
          3. Lipid Nanoparticles
            1. Lipid Nanoparticles By Value
          4. Polymer-based Vectors
            1. Polymer-based Vectors By Value
          5. Others
            1. Others By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
        4. Others
          1. By Value
      3. By Diseases
        1. Introduction
          1. Diseases By Value
        2. Oncology
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
        5. Others
          1. By Value
      4. By End Use
        1. Introduction
          1. End Use By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. CROs
          1. By Value
        5. CDMOs
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Adenoviral vectors
            1. Adenoviral vectors By Value
          3. Adeno associated viral vectors
            1. Adeno associated viral vectors By Value
          4. Retroviral vectors
            1. Retroviral vectors By Value
          5. Lentiviral vectors
            1. Lentiviral vectors By Value
          6. Herpes Simplex Virus (HSV) Vectors
            1. Herpes Simplex Virus (HSV) Vectors By Value
          7. Others
            1. Others By Value
        3. Non-Viral Vectors
          1. By Value
          2. Plasmid DNA
            1. Plasmid DNA By Value
          3. Lipid Nanoparticles
            1. Lipid Nanoparticles By Value
          4. Polymer-based Vectors
            1. Polymer-based Vectors By Value
          5. Others
            1. Others By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
        4. Others
          1. By Value
      3. By Diseases
        1. Introduction
          1. Diseases By Value
        2. Oncology
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
        5. Others
          1. By Value
      4. By End Use
        1. Introduction
          1. End Use By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. CROs
          1. By Value
        5. CDMOs
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Adenoviral vectors
            1. Adenoviral vectors By Value
          3. Adeno associated viral vectors
            1. Adeno associated viral vectors By Value
          4. Retroviral vectors
            1. Retroviral vectors By Value
          5. Lentiviral vectors
            1. Lentiviral vectors By Value
          6. Herpes Simplex Virus (HSV) Vectors
            1. Herpes Simplex Virus (HSV) Vectors By Value
          7. Others
            1. Others By Value
        3. Non-Viral Vectors
          1. By Value
          2. Plasmid DNA
            1. Plasmid DNA By Value
          3. Lipid Nanoparticles
            1. Lipid Nanoparticles By Value
          4. Polymer-based Vectors
            1. Polymer-based Vectors By Value
          5. Others
            1. Others By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
        4. Others
          1. By Value
      3. By Diseases
        1. Introduction
          1. Diseases By Value
        2. Oncology
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
        5. Others
          1. By Value
      4. By End Use
        1. Introduction
          1. End Use By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. CROs
          1. By Value
        5. CDMOs
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Adenoviral vectors
            1. Adenoviral vectors By Value
          3. Adeno associated viral vectors
            1. Adeno associated viral vectors By Value
          4. Retroviral vectors
            1. Retroviral vectors By Value
          5. Lentiviral vectors
            1. Lentiviral vectors By Value
          6. Herpes Simplex Virus (HSV) Vectors
            1. Herpes Simplex Virus (HSV) Vectors By Value
          7. Others
            1. Others By Value
        3. Non-Viral Vectors
          1. By Value
          2. Plasmid DNA
            1. Plasmid DNA By Value
          3. Lipid Nanoparticles
            1. Lipid Nanoparticles By Value
          4. Polymer-based Vectors
            1. Polymer-based Vectors By Value
          5. Others
            1. Others By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
        4. Others
          1. By Value
      3. By Diseases
        1. Introduction
          1. Diseases By Value
        2. Oncology
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
        5. Others
          1. By Value
      4. By End Use
        1. Introduction
          1. End Use By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. CROs
          1. By Value
        5. CDMOs
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Viral Vectors
        1. By Value
        2. Adenoviral vectors
          1. Adenoviral vectors By Value
        3. Adeno associated viral vectors
          1. Adeno associated viral vectors By Value
        4. Retroviral vectors
          1. Retroviral vectors By Value
        5. Lentiviral vectors
          1. Lentiviral vectors By Value
        6. Herpes Simplex Virus (HSV) Vectors
          1. Herpes Simplex Virus (HSV) Vectors By Value
        7. Others
          1. Others By Value
      3. Non-Viral Vectors
        1. By Value
        2. Plasmid DNA
          1. Plasmid DNA By Value
        3. Lipid Nanoparticles
          1. Lipid Nanoparticles By Value
        4. Polymer-based Vectors
          1. Polymer-based Vectors By Value
        5. Others
          1. Others By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Gene Therapy
        1. By Value
      3. Vaccinology
        1. By Value
      4. Others
        1. By Value
    4. By Diseases
      1. Introduction
        1. Diseases By Value
      2. Oncology
        1. By Value
      3. Genetic Disorders
        1. By Value
      4. Infectious Diseases
        1. By Value
      5. Others
        1. By Value
    5. By End Use
      1. Introduction
        1. End Use By Value
      2. Pharmaceutical and Biotechnology Companies
        1. By Value
      3. Academic & Research Institutes
        1. By Value
      4. CROs
        1. By Value
      5. CDMOs
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Viral Vectors
          1. By Value
          2. Adenoviral vectors
            1. Adenoviral vectors By Value
          3. Adeno associated viral vectors
            1. Adeno associated viral vectors By Value
          4. Retroviral vectors
            1. Retroviral vectors By Value
          5. Lentiviral vectors
            1. Lentiviral vectors By Value
          6. Herpes Simplex Virus (HSV) Vectors
            1. Herpes Simplex Virus (HSV) Vectors By Value
          7. Others
            1. Others By Value
        3. Non-Viral Vectors
          1. By Value
          2. Plasmid DNA
            1. Plasmid DNA By Value
          3. Lipid Nanoparticles
            1. Lipid Nanoparticles By Value
          4. Polymer-based Vectors
            1. Polymer-based Vectors By Value
          5. Others
            1. Others By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Gene Therapy
          1. By Value
        3. Vaccinology
          1. By Value
        4. Others
          1. By Value
      3. By Diseases
        1. Introduction
          1. Diseases By Value
        2. Oncology
          1. By Value
        3. Genetic Disorders
          1. By Value
        4. Infectious Diseases
          1. By Value
        5. Others
          1. By Value
      4. By End Use
        1. Introduction
          1. End Use By Value
        2. Pharmaceutical and Biotechnology Companies
          1. By Value
        3. Academic & Research Institutes
          1. By Value
        4. CROs
          1. By Value
        5. CDMOs
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Gene Vector Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Lonza
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. Catalent, Inc
    4. Charles River Laboratories
    5. WuXi AppTec
    6. Oxford Biomedica PLC
    7. Sartorius AG
    8. Takara Bio Inc.
    9. uniQure NV.
    10. Pfizer Inc.
    11. bluebird bio, Inc.
    12. Boehringer Ingelheim International GmbH
    13. Cytiva
    14. Revvity
    15. Forge Biologics
    16. GENE VECTOR BARCELONA S.L.
    17. Miltenyi Biotec
    18. Astellas Pharma Inc.
    19. Dyno
    20. Hoffmann-La Roche Ltd
    21. Others
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.